195 related articles for article (PubMed ID: 21907750)
1. Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.
Li Y; Reddy K; Reid SM; Cox WJ; Brown IH; Britton P; Nair V; Iqbal M
Vaccine; 2011 Oct; 29(46):8257-66. PubMed ID: 21907750
[TBL] [Abstract][Full Text] [Related]
2. Progress toward the development of polyvalent vaccination strategies against multiple viral infections in chickens using herpesvirus of turkeys as vector.
Iqbal M
Bioengineered; 2012; 3(4):222-6. PubMed ID: 22705840
[TBL] [Abstract][Full Text] [Related]
3. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
[TBL] [Abstract][Full Text] [Related]
4. Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site.
Gao H; Cui H; Cui X; Shi X; Zhao Y; Zhao X; Quan Y; Yan S; Zeng W; Wang Y
PLoS One; 2011; 6(7):e22549. PubMed ID: 21818336
[TBL] [Abstract][Full Text] [Related]
5. Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
Andoh K; Yamazaki K; Honda Y; Honda T
Arch Virol; 2017 Apr; 162(4):931-941. PubMed ID: 27942974
[TBL] [Abstract][Full Text] [Related]
6. Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.
Cui H; Gao H; Cui X; Zhao Y; Shi X; Li Q; Yan S; Gao M; Wang M; Liu C; Wang Y
PLoS One; 2013; 8(1):e53340. PubMed ID: 23301062
[TBL] [Abstract][Full Text] [Related]
7. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
[TBL] [Abstract][Full Text] [Related]
8. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
9. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
[TBL] [Abstract][Full Text] [Related]
10. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
[TBL] [Abstract][Full Text] [Related]
11. Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza.
Kapczynski DR; Dorsey K; Chrzastek K; Moraes M; Jackwood M; Hilt D; Gardin Y
Avian Dis; 2016 Jun; 60(2):413-7. PubMed ID: 27309280
[TBL] [Abstract][Full Text] [Related]
12. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge.
Tarpey I; Davis PJ; Sondermeijer P; van Geffen C; Verstegen I; Schijns VE; Kolodsick J; Sundick R
Avian Pathol; 2007 Feb; 36(1):69-74. PubMed ID: 17364512
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF
Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Recombinant HVT-IBD Vaccines Administered to Broiler Chicks from a Single Breeder Flock at 30 and 60 Weeks of Age.
Gelb J; Jackwood DJ; Brannick EM; Ladman BS
Avian Dis; 2016 Sep; 60(3):603-12. PubMed ID: 27610719
[TBL] [Abstract][Full Text] [Related]
15. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek's diseases.
Gergen L; Cook S; Ledesma B; Cress W; Higuchi D; Counts D; Cruz-Coy J; Crouch C; Davis P; Tarpey I; Morsey M
Avian Pathol; 2019 Feb; 48(1):45-56. PubMed ID: 30404540
[TBL] [Abstract][Full Text] [Related]
16. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against Marek's disease and infectious bursal disease. I. Development of a bivalent live vaccine by co-cultivating turkey herpesvirus and infectious bursal disease vaccine viruses in chicken embryo fibroblast monolayers.
Chang JD; Eidson CS; Dykstra MJ; Kleven SH; Fletcher OJ
Poult Sci; 1983 Dec; 62(12):2326-35. PubMed ID: 6322146
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Various HVT Vaccines (Conventional and Recombinant) Against Marek's Disease in Broiler Chickens: Effect of Dose and Age of Vaccination.
Gimeno IM; Cortes AL; Faiz N; Villalobos T; Badillo H; Barbosa T
Avian Dis; 2016 Sep; 60(3):662-8. PubMed ID: 27610727
[TBL] [Abstract][Full Text] [Related]
19. Construction and immune efficacy of a recombinant turkey herpesvirus vaccine strain expressing fusion protein of genotype VII Newcastle disease virus.
Jia W; Zhang X; Wang H; Teng Q; Xue J; Zhang G
Vet Microbiol; 2022 May; 268():109429. PubMed ID: 35421830
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains.
Soejoedono RD; Murtini S; Palya V; Felföldi B; Mató T; Gardin Y
Avian Dis; 2012 Dec; 56(4 Suppl):923-7. PubMed ID: 23402113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
